US FDA Electronic Drug Registrations Key For OTC Monograph Fees Plus Keeping Tabs On Products

FDA drug user fee program chief tells OTC industry stakeholders accurate information in electronic Drug Registration and Listing System is key to setting annual facility registration user fee rates. CDER publishes warning letters to US retailer and a South Korean manufacturer noting noncompliance with eDRLS requirements.

• Source: Shutterstock

The US Food and Drug Administration’s electronic Drug Registration and Listing System is a fulcrum for determining OTC monograph user fees while also setting a requirement the agency again has found firms manufacturing and marketing nonprescription drugs aren’t meeting.

The same day that chief of the FDA’s drug user fee programs advised OTC industry stakeholders that providing accurate information...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Compliance

More from Policy & Regulation